Markets:

Overview

News

Currencies

International

Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

162.32 -5.74 (-3.42%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Illumina, Inc. - Common Stock

< Previous 1 2

...

21 22 23 24 25 26 27 28 Next >

The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales ↗

January 06, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Illumina Announces Co-Development Partnership With SomaScan For Accelerating...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

January 03, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...

Via Benzinga

Why Jim Cramer Likes Illumina, SoFi And More ↗

December 08, 2021

On CNBC’s "Mad Money Lightning Round," Jim Cramer said SoFi Technologies, Inc’s (NASDAQ:

Via Benzinga

Bionano Genomics Proves Not Everything Genetic is Gold ↗

December 01, 2021

Bionano sells a $150,000 machine called Saphyr that does genetic mapping. It's a solid device, but its future remains in the future, as do BNGO stock fortunes.

Via InvestorPlace

Illumina slides after 'Confusing' close of Grail deal amid antitrust probe ↗

August 19, 2021

Citi sees some risk that Illumina's tactic does not sit well with the regulatory bodies.

Via Talk Markets

10x Genomics Stock: Bull vs. Bear ↗

November 24, 2021

After a hot start, the stock has recently lagged the market. Is now a good time to buy?

Via The Motley Fool

Topics Initial Public Offering

Wait for Bionano Stock to Fall Further Before Buying ↗

November 23, 2021

BNGO stock is breaking down following the latest earnings report, and there are no major catalysts to push shares up in the short term.

Via InvestorPlace

Following Rough Year, Is Burning Rock Set To Turn The Corner? ↗

November 18, 2021

Key Takeaways: Burning Rock expects fourth-quarter revenue to grow just 6% year-on-year due to latest Covid-related travel restrictions in China Cancer testing specialist’s...

Via Benzinga

Europe To Layout Objections to Illumina-Grail Deal: Bloomberg ↗

November 16, 2021

Illumina Inc (NASDAQ: ILMN) says the European Union will issue a list of objections tomorrow over the Company's $8B takeover of GRAIL, Bloomberg reports. Related...

Via Benzinga

Illumina Clocks 40% Growth In Q3; Earnings Beat Expectations ↗

November 05, 2021

Illumina Inc (NASDAQ: ILMN) reported Q3 revenues of $1.11 billion, +40% Y/Y, beating the consensus of $1.04 billion. Consolidated Product revenues were $978 million,...

Via Benzinga

Topics Earnings

Illumina, inc (ILMN) Q3 2021 Earnings Call Transcript ↗

November 04, 2021

ILMN earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

After Its Grail Buyout, Illumina Beats Third-Quarter Expectations ↗

November 04, 2021

Illumina stock inched higher late Thursday after the company beat forecasts.

Via Investor's Business Daily

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

'Halftime Report' Final Trades From Oct. 25: Illumina, JPMorgan, And More ↗

October 26, 2021

On CNBC’s "Halftime Report" f...

Via Benzinga

Bet On Biopharma: Data, Digitization, Discovery ↗

October 16, 2021

The after-effects of pandemic-era policies will be with us for some time — with many supply chains still experiencing significant disruption. The worst of this “scarring” will heal. But the...

Via Talk Markets

Illumina Insider Sold $1.2M In Company Stock ↗

October 15, 2021

Alexander Aravanis, SVP And Chief Technology Officer at Illumina (NASDAQ:ILMN), made a large insider sell on October 12, according to a new SEC filing. What Happened: A Form 4...

Via Benzinga

Topics Regulatory Compliance

Why Shares of Ilumina Slumped 11.3% in September ↗

October 06, 2021

The company's merger with GRAIL concerned investors.

Via The Motley Fool

3 Healthcare Stocks to Buy and Hold for the Next 10 Years ↗

September 28, 2021

Some trends will persist for decades.

Via The Motley Fool

UK's NHS Launches World's Largest Trial Of Blood Test For 50 Types ↗

September 13, 2021

Britain's National Health Service (NHS) will begin the world's largest trial of Grail Inc's flagship Galleri blood test that can be used to detect...

Via Benzinga

Illumina, Merck Join Hands For Homologous Recombination Deficiency CDx, Research Assay ↗

September 07, 2021

Illumina Inc (NASDAQ: ILMN) and Merck & Co Inc (NYSE: MRK) provided more details on their partnership to develop and commercialize tests that gauge...

Via Benzinga

Why Illumina Wants Grail Back So Badly ↗

September 04, 2021

The gene-sequencing giant sees a huge opportunity in diagnostics.

Via The Motley Fool

Forget About the Genomic Revolution, the Proteomic Revolution Is Coming ↗

September 03, 2021

Thanks to one small protein sequencing startup, we're entering a new era of proteomics via NGPS technologies that will enable massively parallel protein sequencing.

Via InvestorPlace

Workday And Lam Research Lead The QQQ ↗

August 27, 2021

U.S. indices were trading higher Friday as investors eye Fed Chairman Powell's speech at the Jackson Hole Symposium and gauge Fed tapering policy. The Invesco QQQ Trust...

Via Benzinga

Topics Economy

Looking into Illumina's Return on Capital Employed ↗

August 24, 2021

Pulled from Benzinga Pro data Illumina (NASDAQ:ILMN) showed a loss in earnings since Q1, totaling $187.00 million. Sales, on the other hand, increased by 3.02% to $1.13 billion...

Via Benzinga

Friday Fears and Other Stock News Updates ↗

August 23, 2021

Toyota has cut its output 40% over fear of the Delta variant of Covid, plus shortages of electronics. This is terrifying markets outside the USA. And other global stock news updates.

Via Talk Markets

58 Biggest Movers From Yesterday ↗

August 20, 2021

Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares climbed 63.7% to close at $1.22 on Thursday after dropping 12% on Wednesday. Sonnet BioTherapeutics recently...

Via Benzinga

Microsoft And Cisco Gain As The QQQ Bounces Back Thursday ↗

August 19, 2021

U.S. indices bounced back Thursday after falling Wednesday amid macro uncertainty due to COVID-19 delta variant concerns. The Invesco QQQ Trust Series 1 (NASDAQ: QQQ) gained...

Via Benzinga

Why Illumina Stock Just Dropped 10% ↗

August 19, 2021

The genetic-testing company just blatantly defied its regulators.

Via The Motley Fool

38 Stocks Moving In Thursday's Mid-Day Session ↗

August 19, 2021

Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares jumped 141% to $1.7950 after dropping 12% on Wednesday. Sonnet BioTherapeutics recently reported its financial...

Via Benzinga

< Previous 1 2

...

21 22 23 24 25 26 27 28 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.